Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|April 1, 1982
Captopril kineticsK L Duchin, S M Singhvi, D A Willard, et al.Clinical Pharmacology and Therapeutics|August 1, 1982
Renal handling of captopril: effect of probenecidS M Sinhvi, K L Duchin, D A Willard, et al.Clinical Pharmacology and Therapeutics|January 1, 1980
Effects of nadolol beta-blockade on blood pressure in hypertensionK L Duchin, R A Vukovich, L G Dennick, et al.Journal of Clinical Pharmacology|February 1, 1982
Effect of food on the bioavailability of captopril in healthy subjectsS M Singhvi, D N McKinstry, J M Shaw, et al.Urology|November 1, 1993
Automatic spring-loaded biopsy gun with ultrasonic control for renal transplant biopsyM W McDonald, J T Sosnowski, E J Mahin, et al.British Journal of Clinical Pharmacology|September 1, 1993
Steady state serum concentrations of pravastatin and digoxin when given in combinationJ Triscari, B N Swanson, D A Willard, et al.Journal of Clinical Pharmacology|January 1, 1991
Pharmacokinetics, safety, and pharmacologic effects of fosinopril sodium, an angiotensin-converting enzyme inhibitor in healthy subjectsK L Duchin, A P Waclawski, J I Tu, et al.Clinical Pharmacology and Therapeutics|December 1, 1986
Quantitation of drug levels and platelet receptor blockade caused by a thromboxane antagonistL T Friedhoff, J Manning, P T Funke, et al.British Journal of Clinical Pharmacology|January 1, 1988
Disposition of fosinopril sodium in healthy subjectsS M Singhvi, K L Duchin, R A Morrison, et al.Clinical Pharmacology and Therapeutics|August 1, 1990
Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemiaH Y Pan, A R DeVault, B J Swites, et al.Pageof 3